跳至主要内容
临床试验/CTRI/2024/05/066907
CTRI/2024/05/066907尚未招募2 期

A Clinical and In-Silico Study to Assess the Efficacy of Virechana Followed by Oral Medications and Analysis of Outcomes of Hamsapathyadi Kashayam on THRa And THRß In Hypothyroidism - NI

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients between 21 to 60 years of age of either sex.
  • 2.Patients with the symptomatology of hypothyroidism and elevated TSH.
  • 3.Hypothyroid patients with associated Dyslipidemias [13][14].
  • 4.Patients willing to participate in the trial.

排除标准

  • 1.Conditions contraindicated for Snehana and Virechana Procedure.
  • 2.Any other thyroid pathology or any other endocrine disorders like DM, PCOS, Hyperparathyroidism, etc.
  • 3.Pregnant females and breastfeeding mothers.
  • 4.Any other major systemic illnesses like CAD, IHD, Arrhythmias, Vulvar Heart disease, CVA, Abnormal BP, Aortic Aneurysm, etc.

研究者

相似试验

Evaluating Virechana and Hamsapathyadi Kashayam in... | 临床试验